MS-4 Erlotinib in combination with bevacizumab for patients with recurrent non-small-cell lung cancer: a phase I/II trial
スポンサーリンク
概要
著者
-
Herbst Roy
University Of Texas Md Anderson Cancer Center
-
Sandler Alan
Vanderbilt University
-
Johnson David
Vanderbilt University
-
Blumenschein George
University of Texas MD Anderson Cancer Center
-
Henderson Ted
University of Texas MD Anderson Cancer Center
-
Liu Diane
University of Texas MD Anderson Cancer Center
-
Truong Mylene
University of Texas MD Anderson Cancer Center
-
Ramies David
Genentech Inc.
-
Mass Robert
Genentech Inc.
-
Garcia Ben
Vanderbilt University
関連論文
- MS-4 Erlotinib in combination with bevacizumab for patients with recurrent non-small-cell lung cancer: a phase I/II trial
- Inhibition of angiogenesis in the treatment of non-small cell lung cancer
- Management of Locally Advanced Non-Small Cell Lung Cancer